BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28345263)

  • 1. NMR solution structure of the RED subdomain of the Sleeping Beauty transposase.
    Konnova TA; Singer CM; Nesmelova IV
    Protein Sci; 2017 Jun; 26(6):1171-1181. PubMed ID: 28345263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The folding of the specific DNA recognition subdomain of the sleeping beauty transposase is temperature-dependent and is required for its binding to the transposon DNA.
    Leighton GO; Konnova TA; Idiyatullin B; Hurr SH; Zuev YF; Nesmelova IV
    PLoS One; 2014; 9(11):e112114. PubMed ID: 25375127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR structural analysis of Sleeping Beauty transposase binding to DNA.
    Carpentier CE; Schreifels JM; Aronovich EL; Carlson DF; Hackett PB; Nesmelova IV
    Protein Sci; 2014 Jan; 23(1):23-33. PubMed ID: 24243759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of a bifunctional, paired-like DNA-binding domain and a transpositional enhancer in Sleeping Beauty transposition.
    Izsvák Z; Khare D; Behlke J; Heinemann U; Plasterk RH; Ivics Z
    J Biol Chem; 2002 Sep; 277(37):34581-8. PubMed ID: 12082109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rigidity and flexibility characteristics of DD[E/D]-transposases Mos1 and Sleeping Beauty.
    Singer CM; Joy D; Jacobs DJ; Nesmelova IV
    Proteins; 2019 Apr; 87(4):313-325. PubMed ID: 30582767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleeping Beauty transposase structure allows rational design of hyperactive variants for genetic engineering.
    Voigt F; Wiedemann L; Zuliani C; Querques I; Sebe A; Mátés L; Izsvák Z; Ivics Z; Barabas O
    Nat Commun; 2016 Mar; 7():11126. PubMed ID: 27025571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of hyperactive sleeping beauty transposon vectors by mutational analysis.
    Zayed H; Izsvák Z; Walisko O; Ivics Z
    Mol Ther; 2004 Feb; 9(2):292-304. PubMed ID: 14759813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterselection and co-delivery of transposon and transposase functions for Sleeping Beauty-mediated transposition in cultured mammalian cells.
    Converse AD; Belur LR; Gori JL; Liu G; Amaya F; Aguilar-Cordova E; Hackett PB; McIvor RS
    Biosci Rep; 2004 Dec; 24(6):577-94. PubMed ID: 16158196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells.
    Yant SR; Park J; Huang Y; Mikkelsen JG; Kay MA
    Mol Cell Biol; 2004 Oct; 24(20):9239-47. PubMed ID: 15456893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates.
    Izsvák Z; Ivics Z; Plasterk RH
    J Mol Biol; 2000 Sep; 302(1):93-102. PubMed ID: 10964563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Sleeping Beauty transposition in human cells.
    Ivics Z; Katzer A; Stüwe EE; Fiedler D; Knespel S; Izsvák Z
    Mol Ther; 2007 Jun; 15(6):1137-44. PubMed ID: 17426709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of the Mu end DNA-binding ibeta subdomain of phage Mu transposase: modular DNA recognition by two tethered domains.
    Schumacher S; Clubb RT; Cai M; Mizuuchi K; Clore GM; Gronenborn AM
    EMBO J; 1997 Dec; 16(24):7532-41. PubMed ID: 9405381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulling apart catalytically active Tn5 synaptic complexes using magnetic tweezers.
    Adams CD; Schnurr B; Marko JF; Reznikoff WS
    J Mol Biol; 2007 Mar; 367(2):319-27. PubMed ID: 17257617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleeping Beauty Transposition.
    Ivics Z; Izsvák Z
    Microbiol Spectr; 2015 Apr; 3(2):MDNA3-0042-2014. PubMed ID: 26104705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excision of Sleeping Beauty transposons: parameters and applications to gene therapy.
    Liu G; Aronovich EL; Cui Z; Whitley CB; Hackett PB
    J Gene Med; 2004 May; 6(5):574-83. PubMed ID: 15133768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Determinants of Sleeping Beauty Transposase Activity.
    Abrusán G; Yant SR; Szilágyi A; Marsh JA; Mátés L; Izsvák Z; Barabás O; Ivics Z
    Mol Ther; 2016 Aug; 24(8):1369-77. PubMed ID: 27401040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleeping beauty transposase has an affinity for heterochromatin conformation.
    Ikeda R; Kokubu C; Yusa K; Keng VW; Horie K; Takeda J
    Mol Cell Biol; 2007 Mar; 27(5):1665-76. PubMed ID: 17178833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jumping Ahead with
    Ochmann MT; Ivics Z
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33429848
    [No Abstract]   [Full Text] [Related]  

  • 19. Defining functional regions of the IS903 transposase.
    Tavakoli NP; DeVost J; Derbyshire KM
    J Mol Biol; 1997 Dec; 274(4):491-504. PubMed ID: 9417930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues.
    Wilber A; Frandsen JL; Geurts JL; Largaespada DA; Hackett PB; McIvor RS
    Mol Ther; 2006 Mar; 13(3):625-30. PubMed ID: 16368272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.